Evolução tardia do transplante cardíaco na doença de Chagas: long-term evolution in cardiac transplantation
暂无分享,去创建一个
J. Kalil | G. Bellotti | N. A. Stolf | E. A. Bocchi | A. Jatene | A. Fiorelli | P. A. M. Pomerantzeff | P. Lemos | Pedro Seferian | A. C. Pereira-Barreto | F. Jatene | Tânia Mara Varejão Strabelli | L. Higushi | Uip David | Jorge Newman
[1] J. Remington,et al. In vivo and in vitro effects of cyclosporin A on Trypanosoma cruzi. , 1985, The American journal of tropical medicine and hygiene.
[2] T. Starzl,et al. REVERSIBILITY OF LYMPHOMAS AND LYMPHOPROLIFERATIVE LESIONS DEVELOPING UNDER CYCLOSPORIN-STEROID THERAPY , 1984, The Lancet.
[3] R. Lanza,et al. Malignant neoplasms occurring after cardiac transplantation. , 1983, JAMA.
[4] C. Gottlieb,et al. Exacerbation of Trypanosoma cruzi infection in mice treated with the immunoregulatory agent cyclosporin A. , 1983, Tropenmedizin und Parasitologie.
[5] G. Cole,et al. Inhibition by cyclosporin A of rodent malaria in vivo and human malaria in vitro , 1982, Infection and immunity.